Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,031 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.
Jordan SC, Zakowski P, Tran HP, Smith EA, Gaultier C, Marks G, Zabner R, Lowenstein H, Oft J, Bluen B, Le C, Shane R, Ammerman N, Vo A, Chen P, Kumar S, Toyoda M, Ge S, Huang E. Jordan SC, et al. Among authors: toyoda m. Clin Infect Dis. 2020 Dec 15;71(12):3168-3173. doi: 10.1093/cid/ciaa812. Clin Infect Dis. 2020. PMID: 32575124 Free PMC article.
Interleukin-6: An Important Mediator of Allograft Injury.
Jordan SC, Ammerman N, Choi J, Kumar S, Huang E, Toyoda M, Kim I, Wu G, Vo A. Jordan SC, et al. Among authors: toyoda m. Transplantation. 2020 Dec;104(12):2497-2506. doi: 10.1097/TP.0000000000003249. Transplantation. 2020. PMID: 32235253 Review.
T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals.
Jordan SC, Shin BH, Gadsden TM, Chu M, Petrosyan A, Le CN, Zabner R, Oft J, Pedraza I, Cheng S, Vo A, Ammerman N, Plummer J, Ge S, Froch M, Berg A, Toyoda M, Zhang R. Jordan SC, et al. Among authors: toyoda m. Cell Mol Immunol. 2021 Nov;18(11):2554-2556. doi: 10.1038/s41423-021-00767-9. Epub 2021 Sep 16. Cell Mol Immunol. 2021. PMID: 34531555 Free PMC article. No abstract available.
Divergent Immune Responses to SARS-CoV-2 Vaccines in Immunocompromised Patients.
Jordan SC, Shin BH, Gadsden TM, Chu M, Petrosyan A, Vo A, Ammerman N, Sethi S, Najjar R, Huang E, Peng A, Toyoda M, Kumar S, Zhang R. Jordan SC, et al. Among authors: toyoda m. Transplantation. 2022 Jan 1;106(1):e90-e91. doi: 10.1097/TP.0000000000003957. Transplantation. 2022. PMID: 34582140 Free PMC article.
Clazakizumab for desensitization in highly sensitized patients awaiting transplantation.
Vo AA, Huang E, Ammerman N, Toyoda M, Ge S, Haas M, Zhang X, Peng A, Najjar R, Williamson S, Myers C, Sethi S, Lim K, Choi J, Gillespie M, Tang J, Jordan SC. Vo AA, et al. Among authors: toyoda m. Am J Transplant. 2022 Apr;22(4):1133-1144. doi: 10.1111/ajt.16926. Epub 2021 Dec 30. Am J Transplant. 2022. PMID: 34910841 Free article.
Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts.
Jordan SC, Ammerman N, Choi J, Huang E, Najjar R, Peng A, Sethi S, Sandhu R, Atienza J, Toyoda M, Ge S, Lim K, Gillespie M, Zhang X, Haas M, Vo A. Jordan SC, et al. Among authors: toyoda m. Kidney Int Rep. 2022 Feb 9;7(4):720-731. doi: 10.1016/j.ekir.2022.01.1074. eCollection 2022 Apr. Kidney Int Rep. 2022. PMID: 35497778 Free PMC article.
Current approaches to treatment of antibody-mediated rejection.
Jordan SC, Vo AA, Tyan D, Nast CC, Toyoda M. Jordan SC, et al. Among authors: toyoda m. Pediatr Transplant. 2005 Jun;9(3):408-15. doi: 10.1111/j.1399-3046.2005.00363.x. Pediatr Transplant. 2005. PMID: 15910400 Review.
1,031 results